Home / Poster / Accounting for CYP2C19 mechanism based inhibition and CYP1A2 induction in a PBPK model for omeprazole

Poster

Accounting for CYP2C19 mechanism based inhibition and CYP1A2 induction in a PBPK model for omeprazole

Accounting for CYP2C19 mechanism based inhibition and CYP1A2 induction in a PBPK model for omeprazole

Recommended for you

The Medicine Maker: The Biosimulation Generation

How Model-informed drug development rescue projects from a risky situation

How is the pharmaceutical industry addressing global health inequities?

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

© 2025 Certara. All Rights Reserved. | Privacy policy